Lepromatous leprosy
Exam relevance: in 1 of more than 50 board exam reports · rank 93
- Synonyms
- leprosy, Hansen's disease
- Specialty
- Dermatology · Bacterial infections
- Images
- Histology 1 · Clinical 2
- In the app
- 2 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)
Histology

Definition
Tuberculoid Leprosy (TT)
- Hypopigmented or erythematous, sharply demarcated, anhidrotic plaques with central atrophy.
- Pathognomonic is loss of sensation with impaired temperature/pressure/pain — Early sign: temperature discrimination ↓.
- Nearby peripheral nerves thickened (e.g., ulnar nerve, great auricular nerve, common peroneal nerve) palpable.
- Diffuse skin infiltration with livid nodules, facies leontina, madarosis, saddle nose (nasal mucosa involvement with cartilage destruction), testicular atrophy (M. leprae involvement).
- Peripheral neuropathy with claw hand, foot drop.
- Complications: Glaucoma, keratitis, iridocyclitis (eye involvement), bone destruction (acro-osteolysis), secondary infections.
Classification
Classification (Ridley-Jopling, Immunomodulated Spectrum Form)
| Form & Immune status | Clinical features & Localization |
|---|---|
| TT — Tuberculoid · strong Th1 | 1–3 sharply demarcated, hypopigmented/erythematous plaques with anesthesia and anhidrosis, central atrophy. Few areas. |
| BT — Borderline Tuberculoid · Th1 dominant | 3–10 plaques, moderate extent. |
| BB — Borderline · mixed Th1/Th2 | Many lesions, unstable course, generalized. |
| BL — Borderline Lepromatous · Th2 dominant | Many lesions, generalized. |
| LL — Lepromatous · weak Th2 + anergy | Diffuse infiltrative thickening, facies leontina, madarosis (lateral eyebrows), saddle nose, numerous nodules, high bacterial load, generalized symmetrical. |
Occurrence & epidemiology
Epidemiology & Reporting Obligation
- WHO elimination as a "Public Health Problem" achieved in 2000 (< 1 case / 10,000), but endemic in India, Brazil, Indonesia, Nepal, Africa (~ 200,000 new cases per year worldwide).
- In DE, there is IfSG §7 by name with reporting to health authority.
Aetiopathogenesis
Pathogen & Pathogenesis
- The pathogen is M. leprae, an acid-fast bacterium, obligate intracellular with a generation time of ~14 days — only in animal models (armadillo).
- Transmission: aerogenic droplets with low contagiousness and an incubation period of about 5 years on average (6 months to 20 years).
- Tropism: cooler body regions (skin, peripheral nerves, nasal mucosa) due to the pathogen's heat sensitivity.
Diagnosis
Diagnostics
- Clinical presentation + sensation testing (cotton, needle, temperature).
- Skin biopsy (skin lesion + nerve biopsy) with:
- Ziehl-Neelsen staining (acid-fast bacilli detection in lepromatous form)
- Fite-Faraco staining more sensitive for M. leprae
- PCR (M. leprae DNA) as a sensitive pathogen detection method in paucibacillary forms.
- Lepromin skin test (historical) — shows Th1 reactivity, not for diagnosis but for classification.
- Negative control: sensory examination compared to the contralateral skin area.
Differential diagnoses
Mycosis fungoides
Tinea corporis
Cutaneous leishmaniasis
Lupus erythematosus
Erythema nodosum
Erythema migrans (Lyme disease)
Cutaneous sarcoidosis
Image credits for the thumbnails
- Mycosis fungoides: Wikindrea, “Mycosis Fungoides Before Sun and Cartamo”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Tinea corporis: Corina G., “Tinea corporis”, Public Domain, via Wikimedia Commons · Public domain · Source
- Cutaneous leishmaniasis: Abanima, “Cutaneous leishmaniasis2”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Lupus erythematosus: Meriam Hajji, CC BY 4.0, via Wikimedia Commons · CC BY 4.0 · Source
- Erythema nodosum: James Heilman, MD, “ENlegs”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Erythema migrans (Lyme disease): James Gathany (CDC), “Erythema migrans - erythematous rash in Lyme disease - PHIL 9875”, Public Domain, via Wikimedia Commons · Public domain · Source · CDC PHIL #9875
- Cutaneous sarcoidosis: Nowack et al., “Cutaneous findings in systemic sarcoidosis”, CC BY-SA 2.0, via Wikimedia Commons · CC BY-SA 2.0 · Source
Treatment principles
- Treatment follows the WHO regimen of multidrug therapy combining several antibiotics over many months to prevent resistance; the lepromatous form is classified as multibacillary and is treated for correspondingly longer.
- Leprosy reactions are treated separately with anti-inflammatory therapy, mainly systemic glucocorticoids, and in erythema nodosum leprosum, if necessary, with other immunomodulators.
- Prevention and treatment of nerve damage and disability are central; contacts should be examined.
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
Cross-references
Mentioned in
Keep learning: test yourself
One question from the DermaFuchs app on Lepromatous leprosy – tap an answer.
Question 1 of 1
What is typically the earliest sensory sign of peripheral nerve involvement in leprosy?
Answer
Correct: temperature discrimination ↓. A decrease in temperature discrimination is usually the earliest sign of sensory loss in leprosy lesions.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.